AlphAIalphai — Financial news for AI agents
StockNASDAQ · US · USDHealthcare · Medical Instruments & Supplies

$KMTS

KESTRA MEDICAL TECHNOLOGIES, LTD.

Price · $KMTSvia TradingView
AI sentiment · 7d0 articles

No enriched coverage for $KMTS in the last 7 days.

Insider · 30dAll trades →
Buys
—
0 txs
Sells
$412K
1 txs
Webster Brian Daniel1× · $412K
10b5-1 share of filings100%
See all $KMTS insider activity →
Top stories · $KMTSMore →
AUG 11·yahoo.comMed

Apple downgraded, HPE upgraded: Wall Street's top analyst calls

Morgan Stanley downgraded Apple (AAPL) to Underperform, citing supply-chain checks that Apple cancelled a 20th anniversary all-glass iPhone model; price target cut to $263.66 from $285.56. It upgraded HPE to Overweight, PT $69 (from $71), and NetApp to Equal Weight, PT $173 (from $137). Other analyst actions included upgrades to Qualcomm, SanDisk, Dick’s Sporting, and Everpure, plus downgrades to Teradata, Akamai, Doximity, and Spectrum Brands.

AUG 11·SEC EDGAR

Mahboob Vaseem sold $680K of KMTS

Mahboob Vaseem (Chief Financial Officer) sold 26,287 shares of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) at an average of $25.88 ($25.87–$26.33, $0.68M total) across 2 trades on 2026-08-07 under a Rule 10b5-1 trading plan.

KMTS sentiment & insider activity

Recent KMTS coverage spans insider activity and financial news.

In the last 30 days, KMTS insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($412K). The most active reporter was Webster Brian Daniel, See Remarks, with 1 filing. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.

What's driving KMTS

  • New coverage highlights a product adoption thesis that could influence expectations for future revenue durability.

    yahoo.com · Aug 11, 2026

  • The filing is a routine insider sale, not a new operating or financial catalyst, but it can slightly affect near-term sentiment.

    SEC EDGAR · Aug 11, 2026

  • New coverage with a defined target can shift expectations and flows for KMTS.

    cnbc.com · Aug 10, 2026

  • This is a routine insider open-market sale with no 10b5-1 plan disclosed, which can modestly affect near-term sentiment but is not a fundamental catalyst.

    SEC EDGAR · Aug 6, 2026

  • This is a routine insider sale under a Form 4, with no stated 10b5-1 plan, but it does not disclose new company fundamentals.

    SEC EDGAR · Aug 6, 2026

alphai scores every news story that mentions KMTS with an AI model for sentiment and relevance, and aggregates insider trades from KESTRA MEDICAL TECHNOLOGIES, LTD.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $KMTS

Score
AUG 11$AAPLMedyahoo.com

Apple downgraded, HPE upgraded: Wall Street's top analyst calls

Morgan Stanley downgraded Apple (AAPL) to Underperform, citing supply-chain checks that Apple cancelled a 20th anniversary all-glass iPhone model; price target cut to $263.66 from $285.56. It upgraded HPE to Overweight, PT $69 (from $71), and NetApp to Equal Weight, PT $173 (from $137). Other analyst actions included upgrades to Qualcomm, SanDisk, Dick’s Sporting, and Everpure, plus downgrades to Teradata, Akamai, Doximity, and Spectrum Brands.

4 min read
AUG 10$NVDALowcnbc.com

Here are Monday's biggest analyst calls: Nvidia, Apple, SpaceX, Dick's, Micron, Broadcom, Microsoft & more

Analyst actions on Monday included Bank of America reiterating Nvidia as Buy ahead of earnings, with ~16x CY27 forward P/E. Loop raised FirstCash Holdings to Buy, PT $255, and cut Domino’s to Hold, PT $353. UBS reiterated Micron Buy, PT $1,625. Jefferies downgraded Apple to underperform. Citi reiterated SpaceX Buy, PT $200. Bernstein raised Microsoft PT to $660.

2 min read

Related tickers

More in Medical Instruments & Supplies